Strong clinical data doesn’t just move share prices – it can unlock lucrative global licensing deals for ASX-listed ...

Gold’s outlook is strengthening while Australia’s escalating power volatility opens an infrastructure investment opportunity.

EXIM’s US$860m letter of interest in Graphinex’s Esmeralda graphite project could open up funding for other Australian ...

Think iron ore and coal are too tough to play? These six ASX juniors and mid-tiers have delivered big gains in 2025.